Advances in treatment of recurrent and / or metastatic adenoid cystic carcinoma of salivary glands
10.3760/cma.j.cn113030-20221101-00370
- VernacularTitle:唾液腺复发或转移性腺样囊性癌的治疗进展
- Author:
Yijia HU
1
;
Ye TIAN
;
Shiyu SONG
Author Information
1. 苏州大学附属第二医院肿瘤放射治疗科，苏州 215004
- Keywords:
Head and neck neoplasms;
Salivary gland neoplasms;
Carcinoma, adenoid cystic;
Recurrence;
Metastasis;
Research progress
- From:
Chinese Journal of Radiation Oncology
2023;32(10):934-938
- CountryChina
- Language:Chinese
-
Abstract:
Adenoid cystic carcinoma (ACC) is the second most common pathological subtype of malignant tumors of salivary glands. The incidence of recurrence and metastasis is high after initial treatment. The optimal treatment for these patients is still controversial. In recent years, multiple attempts have been made to treat recurrent and / or metastatic ACC, such as radiation therapy, targeted therapy and immunotherapy. In this article, the treatment options for recurrent and / or metastatic ACC was reviewed and the effect and prospect of each treatment were summarized.
